Table 3.

Sequences of the specific primers used in real-time quantitative PCR.

Gene	Forward sequence (5’-3’)	Reverse sequence (5’-3’)
LAT1	CCAAAGCACGACAGACCTACA	ACCAACCTGGCATATTTCACC
LAT2	GGTGACCACAGGGATAGAGATG	TTGCTTACGGAGGCTGGAACTT
PepT2	TGCACATCCCCTCTCAGTACG	CAAGTCAGTTGGAGCCATTCC
TOR	TCAGGACCTCTTCTCATTGGC	CCTCTCCCACCATGTTTCTCT
AKT1	CACCGTAGAACCGAGCCCGCT	CGCCATGAAGATCCTAAAGAA
S6	GCCAATCTCAGCGTTCTCAAC	CTGCCTAACATCATCCTCCTT
4EBP1	AGCAGGAACTTTCGGTCATA	GTCAATGGGCAGTCAGAAGA
eIF2α	TAAGTCCAGCCCATCCAAAA	CACCCGAGGAGGCCATCAAG
ATF4	GGAGACCAGGAAGATGCGTAG	TGTCCAGCAGCAGTGATGACA
REDD1	TGACCTGTGTCCCTCTAATGA	ATGTGCTCCAGAAGTTTCTCA
TNF-α	CTTCGTCTACAGCCAGGCATCG	TTTGGCCACACCGACCTCACC
IL-8	CGTTGAACAGACTGGGAGAGATG	AGTGGGATGGCTTCATTATCTTGT
5-LOX	GGGATTTTATCGGGGGAC	AACGAGGGAAAGAGGCTG
TGF-β	GCTCAAAGAGAGCGAGGATG	TCCTCTACCATTCGCAATCC
IL-10	CGGCACAGAAATCCCAGAGC	CAGCAGGCTCACAAAATAAACATCT
β-actin	CTCTGGGCAACGGAACCTCT	GTGCGTGACATCAAGGAGAAGC

LAT1, L-type amino acid transporter 1; LAT2 L-type amino acid transporter 2; PepT2, oligopeptide transporter 2; TOR, target of Rapamycin; AKT1, protein kinase B α; S6, ribosomal protein S6; 4EBP-1, eukaryotic initiation factor 4E binding protein 1; eIF2α, eukaryotic initiation factor 2α; ATF4, activating transcription factor 4; REDD1, regulated in development and DNA damage responses 1; TNF-α, tumor necrosis factor α; IL-8, interleukin-8; 5-LOX, 5-lipoxygenase; TGF-β, transforming growth factor β; IL-10, interleukin-10.